Beta carboline derivatives useful in the treatment of proliferative disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9168247
APP PUB NO 20130116273A1
SERIAL NO

13704109

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) useful in the treatment of proliferative disorders including cancer, intermediates used in their preparation, processes for preparing the same and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE LIBRE DE BRUXELLESBRUXELLES
FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX61 RUE DE BRUXELLES NAMUR B-5000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bruyere, Celine Forest, BE 1 11
Frederick, Raphael Godinne, BE 1 11
Kiss, Robert Sint-Pieters-Leeuw, BE 27 93
Masereel, Bernard Fize-Fontaine, BE 5 42
Mathieu, Véronique Emmanuelle Julie Brussels, BE 1 4
Meinguet, Céline Anne Marie Michelle Ciney, BE 1 4
Reniers, Jeremy Biercee, BE 1 11
Wouters, Johan Beez, BE 15 935

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 27, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00